Insider filing · EWTX
Joanne M. Donovan
CMO
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
Joanne M. Donovan sold $691K of Edgewise Therapeutics (EWTX)
Executed Jan 28 2025, disclosed Jan 30 2025, 2 days later.
Value, as filed
$691K
25,000 sh × $27.63
Executed
Jan 28 2025
the trade date, as filed
Disclosed
Jan 30 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJoanne M. Donovan (CMO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $2.1M of EWTX (55,230 sh across 2 lots, as filed), executed May 4.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Joanne M. Donovan in EWTX
EWTXSALE
Edgewise Therapeutics, Inc.
$372K8,537 sh across 3 lots
Exec Aug 12
Filed Aug 14 · 4:54 PM ET EWTXSALE Edgewise Therapeutics, Inc. $2.1M
55,230 sh across 2 lots
Exec May 4
Filed May 5 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $926K
28,662 sh × $32.31
Exec Apr 1
Filed Apr 2 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $685K
21,338 sh × $32.12
Exec Mar 31
Filed Mar 31 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $507K
16,358 sh across 2 lots
Exec Mar 27
Filed Mar 30 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $203K
7,162 sh × $28.29
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET